Post-approval studies (Phase 4)Study completedNCT01106534
What this trial is testing
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Who this might be right for
Chronic Total Occlusion of Coronary ArteryVascular DiseaseMyocardial Ischemia+4 more
Abbott Medical Devices 870